Press release
Lawsuit filed for Investors who lost money with shares of DexCom, Inc. (NASDAQ: DXCM)
A lawsuit was filed on behalf of investors in DexCom, Inc. (NASDAQ: DXCM) shares over alleged securities laws violations.
Investors who purchased shares of DexCom, Inc. (NASDAQ: DXCM) have certain options and for certain investors are short and strict deadlines running. Deadline: October 21, 2024. NASDAQ: DXCM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. DexCom, Inc. reported that its annual Total Revenue rose from over $2.9 billion in 2022 to over $3.62 billion in 2023, and that its Net Income increased from $341.2 million in 2022 to $541.5 million in 2023 in 2023.
On July 25, 2024, after the closure of market trading, DexCom, Inc. announced its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company's performance did not meet its established high standards of execution. Furthermore, DexCom revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to "certain unique items impacting 2024 seasonality," which have been identified as factors influencing the Company's financial outlook.
Shares of DexCom, Inc. (NASDAQ: DXCM) declined from $142 per share on March 26, 2024, to as low as $62.34 per share on July 26, 2024.
The plaintiff claims that between January 8, 2024 to July 25, 2024, the defendants failed to disclose the true state of DexCom's salesforce, that DexCom, Inc was not truly equipped to execute on the Company's perceived growth potential, and that as a result of their purchases of DexCom's common stock between January 8, 2024 to July 25, 2024, investors suffered economic loss.
Those who purchased shares of DexCom, Inc. (NASDAQ: DXCM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of DexCom, Inc. (NASDAQ: DXCM) here
News-ID: 3661670 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced.
Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a…
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options…
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for DexCom
Diabetes Care Devices Market Massive Growth opportunity Ahead | Medtronic, Abbot …
On February 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Diabetes Care Devices Market". In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Diabetes Care Devices Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic…
mHealth Market Next Big Thing | Major Giants- Fitbit, DEXCOM, Boston Scientific
Market Research Forecast published a new research publication on "mHealth Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the mHealth market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in the study…
Wearable Glucometers Market | Abbott Laboratories, Bayer, Dexcom, DiaMon Tech Gm …
The global wearable glucometers market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the wearable glucometers market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
mHealth Market To Witness Superb Growth | Dexcom, WellDoc, Claritas MindSciences
The latest analysis released by HTF MI on "Global mHealth Market Outlook 2020 Survey results" sheds light on how investment and competitive landscape is impacted due to significant changes in the mHealth Industry. The research coverage includes analysis on companies such as Pear Therapeutics, Inc., Ginger.io, Inc., Livongo Health, Withings, Propeller Health, Mango Health, Twine Health, Inc., Digital Therapeutics, Proteus Digital Health, Dexcom, Inc., WellDoc, Inc., Claritas MindSciences, Jawbone, Canary…
Diabetes Monitors Market Is Booming Worldwide | Dexcom, Roche, Medtronic
HTF MI released new intelligence report on "Worldwide Diabetes Monitors Market" aiming to deliver competitive advantage. The study discusses how various medical equipment manufacturers are reinventing their Worldwide Diabetes Monitors business and operating models with future outlook. Some of the Manufacturers considered in the study are Panasonic, Abbott Laboratories, Dexcom, Roche, Medtronic, LifeScan & Sanofi etc.
Get an Inside Scoop of Worldwide Diabetes Monitors Market Studyhttps://www.htfmarketreport.com/sample-report/3587011-worldwide-diabetes-monitors-market
The Worldwide Diabetes Monitors market study…
Diabetes Management Software Market- Key Vendors ( Glooko, OneTouch, Dexcom Clar …
The diabetes management software market has been expanding alongside the effort of the healthcare industry to induct the best facilities for treatment and care of diabetic patients. It is expected that the demand for diabetes management software would flow in from private clinics as well as hospitals in the forthcoming years. This is because both of these units witness an influx of patients suffering from diabetes on a daily basis.…
